Yifeng Pharmacy Chain Co (603939.SS) Stock Price

Yifeng Pharmacy Chain Co Price

SSE·CLOSED
26.73
​
Market closed

Revenue has compounded at 23.8% per year over the past 14 years to 24.43 B CNY. Earnings per share have grown at 27.5% per year over the last 14 years. Yifeng Pharmacy Chain Co's net margin stands at 6.9%, up from 5.8% several years earlier. Yifeng Pharmacy Chain Co currently offers a dividend yield of about 2.62%. The payout ratio is around 51% of earnings. The dividend has grown at 23.9% per year over the past 10 years. Analysts set a median price target of 34.17 CNY, implying 27.8% above the current price. Of 20 analysts, 17 rate the stock a buy — an overall Buy consensus.

Yifeng Pharmacy Chain Co stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Yifeng Pharmacy Chain Co business model & stock analysis

Yifeng Pharmacy Chain Co., Ltd. engages in the chain retailing of pharmaceuticals, health products, medical equipment and health-related household convenience products. The company is headquartered in Changsha, Hunan and currently employs 35,915 full-time employees. The company went IPO on 2015-02-17. The firm mainly operates through retailing segment. The firm operates more than 1, 000 direct pharmaceutical chain stores mainly in six provinces (or municipalities), including Hunan, Hubei, Shanghai, Jiangsu, Zhejiang and Jiangxi. The retail products of the Company includes pharmaceuticals, medical equipment, health products, health food, personal care products and maternal and child products. The firm is also engaged in the wholesale business through its subsidiary, Hunan Yifeng Pharmaceutical Co., Ltd.

Frequently asked questions about Yifeng Pharmacy Chain Co

Analysts currently set an average price target of 33.66 CNY for the Yifeng Pharmacy Chain Co stock (median: 34.17 CNY), implying +28.2 % versus the latest price. The consensus is based on 20 analyst ratings.

20 analysts currently rate the Yifeng Pharmacy Chain Co stock: 17 recommend buying, 2 holding and 1 selling. For 2026, analysts expect Yifeng Pharmacy Chain Co to generate revenue of 25.98 B CNY and earnings per share of 1.57 CNY.

Converted at the current exchange rate, the Yifeng Pharmacy Chain Co share trades at 3.64 EUR (26.73 CNY).

The Yifeng Pharmacy Chain Co share (603939.SS) is listed on 1 stock exchanges, including: Shanghai (603939.SS).

The expected revenue of Yifeng Pharmacy Chain Co is 25.98 B CNY. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Yifeng Pharmacy Chain Co is 1.91 B CNY. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Yifeng Pharmacy Chain Co is currently 17.00. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Yifeng Pharmacy Chain Co stock.

The price-to-sales ratio (P/S) of Yifeng Pharmacy Chain Co is currently 1.25. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Yifeng Pharmacy Chain Co stock.

The Eulerpool Quality Score for Yifeng Pharmacy Chain Co is 8/10.

The ISIN of Yifeng Pharmacy Chain Co is CNE100001TS5. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Yifeng Pharmacy Chain Co is 603939.SS. The ticker symbol is used to trade Yifeng Pharmacy Chain Co shares on the stock exchange.

Fair ValueTerminal
28.07 CNY
Over-/UndervaluationTerminal
Fairly valued
Industry
Consumer Staples Distribution & Retail
Number of shares
Employees
Revenue per Employee
680,305.33 CNY
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website yfdyf.cn
Country
Currency
CNY
Initial public offering
Feb 17, 2015
ISIN
CNE100001TS5
Cusip
Y982AC104
Market capitalization
32.95 B CNYLarge Cap
52-Week Range
PEG
3.73
P/E ratio
P/Ee 2026
17.28
P/Ee 2027
15.25
P/Ee 2028
13.51
P/Ee 2029
11.86
P/Ee 2030
13.43
P/S
P/Se
1.25
EV/EBIT
12.54
P/B Ratio
2.83
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
12.63 %
Dividend
Dividend yield
2.62 %
Est. Dividend Yield
1.50 %
Payout Ratio
50.56 %
Dividend growth Ø5Y
17.50 %
Dividend payments per year
2
Dividend paid since
9 years
Dividend not reduced since
0 years
Dividend increased since
0 years
Dividend withholding tax
10.00 %
Last updated Nov 21, 2026, 3:34 AM

Yifeng Pharmacy Chain Co Peer Group

Yifeng Pharmacy Chain Co Ticker

SHH · 603939.SS

Yifeng Pharmacy Chain Co FIGI

603939:CH · BBG0058YKFH1603939:CG · BBG006KZTN13603939:C1 · BBG00D1Z9GV3

All fundamentals and in-depth analysis of Yifeng Pharmacy Chain Co

Our stock analysis for Yifeng Pharmacy Chain Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Yifeng Pharmacy Chain Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.